Cargando…

Amyloid-beta 42 adsorption following serial tube transfer

INTRODUCTION: Cerebrospinal fluid (CSF) amyloid-beta 38 (Aβ38), 40 (Aβ40), 42 (Aβ42) and total tau (T-tau) are finding increasing utility as biomarkers of Alzheimer’s disease (AD). The purpose of this study was to determine whether measured CSF biomarker concentrations were affected by transfer of C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toombs, Jamie, Paterson, Ross W, Schott, Jonathan M, Zetterberg, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059346/ https://www.ncbi.nlm.nih.gov/pubmed/24472496 http://dx.doi.org/10.1186/alzrt236

Ejemplares similares

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
por: Paterson, Ross W., et al.
Publicado: (2015)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios
por: Toombs, Jamie, et al.
Publicado: (2018)

Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
por: Banerjee, Gargi, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2020)

Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia
por: Arber, Charles, et al.
Publicado: (2021)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
por: Maity, Sibaprasad, et al.
Publicado: (2020)

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
por: Wang, Pei‐Ning, et al.
Publicado: (2020)

Adsorption of Amyloid Beta Peptide by Metal–Organic Frameworks
por: Mensinger, Zachary L., et al.
Publicado: (2020)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
por: Sinclair, Patricia, et al.
Publicado: (2021)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

The Role of Age on Beta-Amyloid(1–42) Plasma Levels in Healthy Subjects
por: Zecca, Chiara, et al.
Publicado: (2021)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study
por: Wiest, Reiner, et al.
Publicado: (2021)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
por: Bjerke, Maria, et al.
Publicado: (2010)

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
por: Michno, Wojciech, et al.
Publicado: (2019)

Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017)

Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout
por: Arber, Charles, et al.
Publicado: (2019)

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF
por: Kollhoff, Alexander L., et al.
Publicado: (2018)

Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018)

Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Samples
por: Wongta, Anurak, et al.
Publicado: (2020)

Amyloid beta-42 Levels in Companion Dog Brains Correlate with Age and Cognitive Function
por: Urfer, Silvan, et al.
Publicado: (2020)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells
por: Sinclair, Patricia, et al.
Publicado: (2022)

Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42
por: Zaretsky, Dmitry V., et al.
Publicado: (2022)

Hypochlorite-induced oxidation promotes aggregation and reduces toxicity of amyloid beta 1-42
por: Mañucat-Tan, Noralyn B., et al.
Publicado: (2023)

Novel Neuroprotective Function of Apical-Basal Polarity Gene Crumbs in Amyloid Beta 42 (Aβ42) Mediated Neurodegeneration
por: Steffensmeier, Andrew M., et al.
Publicado: (2013)

The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid
por: Ellis, Teresa A., et al.
Publicado: (2012)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

The Acute Effects of Amyloid-Beta(1–42) on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus
por: Yeung, Jason H. Y., et al.
Publicado: (2020)

Beta-Amyloid (Aβ(1-42)) Increases the Expression of NKCC1 in the Mouse Hippocampus
por: Lam, Patricia, et al.
Publicado: (2022)

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease
por: Fertan, Emre, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5piqkdjq82k3vcv2nssc1bt1g